Friday, 3 May 2013

Scientists decode "molecular chatter" that causes spread of cancer cells

For the first time, US scientists have decoded the "molecular chatter" that makes cancer cells more aggressive and more likely to form tumours in other parts of the body. The discovery occurred as a result of bringing together specialists in cancer development with specialists in wound healing.

Principal investigator Prof Russell Taichman, from the University of Michigan, and colleagues, wrote about their discovery in the online issue of Nature Communications.

It is becoming increasingly clear that cancer cells are well-travelled adversaries that are capable of side-stepping the treatments we throw at them to try and stop their spread. For instance, a recent study that produced a catalogue of the physical properties of cancer cells, found they are nimbler and more aggressive than healthy cells because they are better able to pass through small spaces, and they exert a greater force on their environment. Now Taichman and colleagues have discovered a set of molecular signals that causes them to go into overdrive and spread.

For some time, scientists have known that tumours summon the body's healing cells, which is a major reason cancer is difficult to treat. A cancerous tumour acts like a wound that just won't heal: just like a benign tumour it sends out distress signals that recruit mesenchymal stem cells (MSCs) to heal it. These stem cells are then able to turn into several types of cell depending on the specific signals sent by the tumour. What Taichman and colleagues discovered is that when MSCs and cancer cells interact, the molecular messages that pass between them appear to send the cancer cells into overdrive and increase their ability to metastasise. He and his colleagues believe theirs is the first known study to explain molecular behaviour behind the series of changes that happen in the healing cells that result in cancer spread.

The interaction they decoded starts with a signal called CXCR6, which triggers the conversion of MSCs into fibroblasts, setting off a cascade that boosts metastasis:
"CXCR6 signalling stimulates the conversion of mesenchymal stem cells into cancer-associated fibroblasts, which secrete stromal-derived factor-1, also known as CXCL12. CXCL12 expressed by cancer-associated fibroblasts then binds to CXCR4 on tumour cells and induces an epithelial-to-mesenchymal transition, which ultimately promotes metastasis to secondary tumour sites."
This unique result was made possible because half of the researchers that worked on the study are experts in tumour development, and the other half are experts on wound healing. It came about because research associate Younghun Jung, who works in Taichman's lab and is first author of the paper, works in both fields. Taichman explains that it was her who put the two together and came up with the idea. Therefore this study is a good example of how surprising and useful discoveries in research can result from multidisciplinary work.

Jack

No comments:

Post a Comment